Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

COTTONE, Mario
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.521
EU - Europa 3.482
AS - Asia 888
OC - Oceania 19
AF - Africa 15
SA - Sud America 11
Continente sconosciuto - Info sul continente non disponibili 4
Totale 12.940
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.429
IT - Italia 910
UA - Ucraina 760
CN - Cina 532
FI - Finlandia 434
DE - Germania 330
GB - Regno Unito 292
IE - Irlanda 277
SG - Singapore 153
RU - Federazione Russa 112
SE - Svezia 108
CA - Canada 88
FR - Francia 74
IN - India 69
BE - Belgio 43
KR - Corea 42
RO - Romania 28
NL - Olanda 26
ES - Italia 22
AU - Australia 18
CH - Svizzera 17
MY - Malesia 15
TR - Turchia 14
PL - Polonia 13
HK - Hong Kong 9
GR - Grecia 8
AT - Austria 7
IR - Iran 6
JP - Giappone 6
LB - Libano 6
PK - Pakistan 6
RS - Serbia 6
UZ - Uzbekistan 6
EG - Egitto 5
EU - Europa 4
ID - Indonesia 4
NG - Nigeria 4
PT - Portogallo 4
ZA - Sudafrica 4
BR - Brasile 3
IL - Israele 3
MX - Messico 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
CL - Cile 2
CM - Camerun 2
CZ - Repubblica Ceca 2
IQ - Iraq 2
LK - Sri Lanka 2
NO - Norvegia 2
PH - Filippine 2
UY - Uruguay 2
AL - Albania 1
AR - Argentina 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BY - Bielorussia 1
CO - Colombia 1
CY - Cipro 1
DK - Danimarca 1
EC - Ecuador 1
EE - Estonia 1
HR - Croazia 1
LU - Lussemburgo 1
MN - Mongolia 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
PS - Palestinian Territory 1
SA - Arabia Saudita 1
VE - Venezuela 1
VN - Vietnam 1
Totale 12.940
Salva come PNG Salva come JPEG
Città #
Fairfield 1.141
Woodbridge 876
Ashburn 744
Chandler 657
Houston 615
Wilmington 466
Jacksonville 439
Ann Arbor 438
Seattle 417
Cambridge 387
Dublin 276
Palermo 215
Medford 210
Nanjing 159
Princeton 139
Altamura 126
Singapore 107
Tulsa 107
Dearborn 91
Lawrence 89
Des Moines 82
Boardman 79
San Diego 72
Munich 63
Montréal 61
Beijing 59
Mcallen 58
Shenyang 49
Nanchang 46
Venice 42
Brussels 41
Kumar 41
Milan 39
Ludwigshafen am Rhein 38
Seongnam 37
Los Angeles 36
Jiaxing 32
Santa Clara 31
Tianjin 31
Redwood City 30
Hebei 28
London 26
Saint Petersburg 26
Changsha 25
Auburn Hills 22
Jinan 21
New York 21
Phoenix 21
San Paolo di Civitate 21
Omaha 18
Verona 18
San Mateo 16
Rome 15
Orange 13
Washington 13
Falls Church 12
Pune 12
Zhengzhou 11
Lanzhou 10
Bremen 9
Den Haag 9
Indiana 9
Izmir 9
Central District 8
Guangzhou 8
Bergamo 7
Chicago 7
Moscow 7
Ningbo 7
Norwalk 7
Petaling Jaya 7
Shanghai 7
Belgrade 6
Edinburgh 6
Taizhou 6
West Chicago 6
Amsterdam 5
Atlanta 5
Düsseldorf 5
Genova 5
Haikou 5
Hangzhou 5
Hyderabad 5
Islington 5
Kilburn 5
Kuala Lumpur 5
Lewiston 5
Mountain View 5
Salerno 5
Toronto 5
Zurich 5
Charlotte 4
Kraków 4
Kunming 4
Melbourne 4
Messina 4
Milazzo 4
Multan 4
San Francisco 4
Stellenbosch 4
Totale 9.251
Salva come PNG Salva come JPEG
Nome #
NUTRITION, MALNUTRITION AND DIETARY INTERVENTIONS IN INFLAMMATORY BOWEL DISEASE 405
Prurigo nodularis of Hyde treated with low-dose thalidomide. 298
Physicians' Knowledge and Application of Immunization Strategies in Patients with Inflammatory Bowel Disease: A Survey of the Italian Group for the Study of Inflammatory Bowel Disease 158
An open-safety study of dual antiviral therapy in real-world patients with chronic hepatitis C 151
Overexpression of interleukin-23, but not interleukin-17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis 148
Budesonide MMX and mesalamine to induce remission in patients with ulcerative colitis 148
Clinical benefit of vedolizumab on articular manifestations in patients with active spondyloarthritis associated with inflammatory bowel disease 148
Frequency of NOD2/CARD15 variants in both sporadic and familial cases of Crohn's disease across Italy. An Italian Group for Inflammatory Bowel Disease study 146
JC Virus, Helicobacter pylori, and Oesophageal Achalasia: Preliminary Results from a Retrospective Case-Control Study. 146
Severe acute colitis associated with CMV:a prevalence study 145
Cyclosporine or infliximab as rescue therapy in severe 2 refractory ulcerative colitis: Early and long-term data 3 from a retrospective observational study 144
Infliximab and ulcerative colitis 139
Efficacy and safety of endoscopic balloon dilation of symptomatic intestinal Crohn's disease strictures. 139
An Unusual Presentation of Zollinger-Ellison Syndrome 138
Methodological problems in RCTs on IBD 137
A. Optimization of the treatment with immunosuppressants and biologics in inflammatory bowel disease. 137
Heart failure and anti tumor necrosis factor-alpha in systemic chronic inflammatory diseases. 137
Oral lichen planus after certolizumab pegol treatment in a patient with Crohn's disease 135
Postoperative maintenance therapy for inflammatory bowel disease 135
The frame.shift mutation of the NOD2/Card15 gene is significantly increased in ulcerative colitis: an IG-IBD study 134
Incidence of Crohn's disease and Card 15 mutation in a small township in Sicily 132
Beclomethasone dipropionate in Crohn's ileitis: A randomised, double-blind trial. 131
The role of portal vein thrombosis in the clinical course of inflammatory bowel diseases: report on three cases and review of the literature. 130
Complete clinical remission after high dose immune suppression and autologous hematopoietic stem cell transplantation in severe Crohn's disease refractory to immunosuppressive and immunomodulator therapy 129
Clinical and endoscopic presentation of primary gastric lymphoma:a multicenter study 128
Meta-analysis of the placebo rates of clinical relapse and severe endoscopic recurrence in post-operative Crohn's disease 126
Advanced age is an independent risk factor for severe infections and mortality in patients given anti-tumor necrosis factor therapy for inflammatory bowel disease. 126
Systematic review: macrophage activation syndrome in inflammatory bowel disease 125
Crohn's disease:a comparative prospective study of transabdominal ultrasonography,small intestine contrastultrasonography and small bowel enema 123
A rare case of ulcerative proctitis associated with type B lymphomatoid papulosis and superimposed human cytomegalovirus infection. 123
COULD JC VIRUS PROVOKE METASTASIS IN COLON CANCER? 122
Meta-analysis: remission and response from control arms of randomized trials of biological therapies for active luminal Crohn's disease. 122
Methodology for high-quality studies on course and prognosis of inflammatory bowel disease. 121
Toxic megacolon and human Cytomegalovirus in a series of severe ulcerative colitis patients 121
Leucocytapheresis in patients with moderate severe steroid dependant Ulcerative Colitis:clinical response without endoscopic response 120
Cancer in Crohn's Disease patients treated with infliximab: A long-term multicenter matched pair study 119
Improving patients Qol:how the success of treatment can improve workability 118
Clinical course of ulcerative colitis 117
Tofacitinib in active ulcerative colitis 117
EFFICACY AND SAFETY OF ENDOSCOPIC BALLOON DILATION OF SYMPTOMATIC INTESTINAL CROHN'S DISEASE STRICTURES 116
An unusual presentation of T-lymphoma in a Crohn's 4 disease patient treated with combo therapy: We are 5 willing to take a risk of serious adverse events for a 6 doubtful benefit? 115
MINIMIZING INFLIXIMAB TOXICITY IN THE TREATMENT OF INFLAMMATORY BOWEL DISEASE 114
Infliximab, azathioprine or combination therapy in the treatment of active Crohn's disease. 114
A Propensity Score-matched Comparison of Infliximab and Adalimumab in Tumour Necrosis Factor-α Inhibitor-naïve and Non-naïve Patients with Crohn's Disease: Real-Life Data from the Sicilian Network for Inflammatory Bowel Disease 111
Unusual perforation after balloon dilation in a Crohn's disease patient:report of a case 110
Six year adalimumab efficacy in steroid-dependent Crohn's disease patients: A prospective single-center real life study 110
IL-23R determines susceptibility in Crohn's disease in a Mediterranean area 108
Successful induction of clinical response and remission with certolizumab pegol in Crohn's disease patients refractory or intolerant to infliximab: a real-life multicenter experience of compassionate use. 106
Over-expression of paneth cell-derived anti-microbial peptides in the gut of patients with ankylosing spondylitis and subclinical intestinal inflammation. 103
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. 102
Is 5-ASA Still the Treatment of Choice for Ulcerative Colitis? 102
COLORECTAL CANCER IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: PRELIMINARY RESULTS FROM AN ONGOING CASE-CONTROL STUDY 100
Infliximab prevents Crohn's disease recurrence after ileal resection. 100
Cancer in Infliximab-treated or untreated crohn's disease patients:a 2 years longer follow-up from a multicenter matched pair study 99
Antibiotic treatment of Crohn's disease:results of a multicentre double blind randomized placebo controlled trial with Rifamixin 99
Infliximab to treat Crohn's disease: an update 98
Radiofrequency thermal ablation vs percutaneous ethanol injection for small hcc in cirrhosis:metanalysis of randomized controlled trials 97
Investigational agents for Crohn's disease. 96
Proteins encoded in genomic regions associated with immune-mediated disease physically interact and suggest underlying biology. 96
Cytomegalovirus disappearance after treatment for refractory ulcerative colitis in 2 patients treated with infliximab and 1 patient with leukapheresis 95
Early postoperative recurrence of severe crohn's disease, with colonic involvement and associated human cytomegalovirus infection, treated with oral valganciclovir and adalimumab. 95
Infliximab in the treatment of Crohn's disease :predictors of response in an Italian multicenter open study 94
Marked impact of IL28B genotype in the natural clearance of hepatitis C virus in patients with haemoglobinopathies. 94
Smoking therapy may be an extreme cure in exsmokers with steroid-dependent and resistant ulcerative colitis. 93
Intestinal permeability and Genetic determinants in patients,first degree relatives,and controls in a High incidence area's of Crohn's disease in Southern Italy 91
Psychopharmacology treatment and psychological interventions in irritable bowel syndromel 91
PREVALENCE OF CARD15/NOD2 MUTATIONS IN SICILIAN POPULATION 90
CLINICAL COURSE OF SEVERE COLITIS: A COMPARISON BETWEEN CROHN'S DISEASE AND ULCERATIVE COLITIS. 89
The role of calprotectin in predicting endoscopic post-surgical recurrence in asymptomatic Crohn's disease: a comparison with ultrasound 88
Placebo Therapy in Crohn's disease 87
Burden of Crohn's disease: economics and quality of life aspects in Italy. 87
Calprotectin in the prediction of endoscopic post-surgical recurrence in CD 86
Oral valganciclovir for coloni c dilatation in ulcerative colitis associated with Human cytomegalovirus infection 86
Probiotics, prebiotics and symbiotics in inflammatory bowel diseases: state-of-the-art and new insights 86
Radiologia e malattia celiaca dell'adulto 85
THE ROLE OF CARD15 MUTATIONS AND SMOKING IN THE COURSE OF DISEASE IN A MEDITERRANEAN AREA 84
INFLIXIMAB FOR PEDIATRIC ULCERATIVE COLITIS:A RETROSPECTIVE ITALIAN MULTICENTER STUDY 84
A real life comparison of the efficacy of adalimumab versus golimumab in moderate-to-severe ulcerative colitis. A multicenter experience from the sicilian network for inflammatory bowel disease (SN-IBD) 83
Severe cutaneous psoriasis after certolizumab pegol treatment;report of a case. 82
Is splenectomy a treatment option for aseptic abscesses in patients with Crohn's disease? 82
VALIDATION OF A MODIFIED MODEL OF TNBS-INDUCED COLITIS IN RATS. HOW TO INDUCE A CHEMICAL COLITIS IN RATS. 82
The sicilian network for inflammatory bowel disease (SN-IBD): preliminary data on efficacy of biological therapy. 81
Cytomegalovirus and Inflammmatory bowel disease:is there a link ? 80
NEWLY DIAGNOSED NEOPLASIA IN CROHN DISESE PATIENTS TREATED WITH INFLIXIMAB;A 1 YEAR LONGER FOLLOW UP FROM A MULTICENTER MATCHED PAIR STUDY 79
ATG16L1 contribution to Crohn's disease risk in Sicily 79
RADIO FREQUENCY THERMAL ABLATION VS PERCUTANEOUS ETHANOL INJECTION FORM SMALL HEPATOCELLULAR CARCINOMA IN CIRRHOSIS:META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS. 78
Appropriateness of immunosupprerssive drugs in inflammatory bowel disease assessed by RAND method :Italian group for IBD position statement 78
CA-19 to rule out Pancreatic or Biliary Cancer among patients with cholestasis:an unsuitable ? 78
Adalimumab in steroid-dependent Crohn's disease patients: Prognostic factors for clinical benefit 78
UNRESECTABLE HEPATOCELLULAR CARCINOMA:META-ANALYSIS OD ARTERIAL EMBOLIZATION 75
Gastrointestinal lesions associated with spondyloarthropathies. 75
Natural history of cytomegalovirus infection in a cohort of patients diagnosed with moderate severe ulcerative colitis 74
Management and long-term follow-up of early stage H. pylori-associated gastric MALT-lymphoma in clinical practice: an Italian, multicentre study. 74
A real life comparison of the effectiveness of adalimumab and golimumab in moderate-to-severe ulcerative colitis, supported by propensity score analysis. 74
Persistence on Anti-Tumour Necrosis Factor Therapy in Older Patients with Inflammatory Bowel Disease Compared with Younger Patients: Data from the Sicilian Network for Inflammatory Bowel Diseases (SN-IBD). 74
The role of NOD2/CARD15 mutation and smoking in the course of Crohn's disease in a Mediterranean area 70
Infliximab and newly diagnosed neoplasia in CD:a multicenter matched pair study 70
Incidence of HSV and HPV with azathioprine 70
Natural history of Cytomegalovirus infection diagnosed with moderate-severe ulcerative colitis 70
Familial mediterranea fever mutations in Crohn's disease in a Mediterranea area 69
Totale 11.074
Salva come PNG Salva come JPEG
Categoria #
all - tutte 48.359
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.359
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.041 0 0 263 337 429 528 405 224 378 150 159 168
2020/20211.844 89 179 95 202 142 63 170 102 246 179 171 206
2021/20221.472 62 376 21 51 43 54 85 67 162 199 84 268
2022/20231.900 202 365 35 185 242 260 71 172 245 12 91 20
2023/2024781 46 145 39 53 91 150 75 34 2 54 32 60
2024/2025203 49 101 53 0 0 0 0 0 0 0 0 0
Totale 13.231